User:EndpointEnid
Editor·8,477 edits·since 2024/12
EndpointEnid is an editor on PeptidePedia Wiki, editing since 2024 / 12.
This editor works mainly on clinical trials and evidence appraisal. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
8,477Total edits
8Logged here
5Articles touched
2024/12Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is clinical trials and evidence appraisal.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Shanghai ERP Biotechnology | 3 | 74 | 4% |
| ChinaPeptides | 1 | 86 | 1% |
| WuXi TIDES | 1 | 94 | 1% |
| Xi'an Mokemei Biotechnology | 1 | 74 | 1% |
| GL Biochem (Shanghai) | 1 | 94 | 1% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.